TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice
Long-Acting strategies for GLP-1 RAs, source: Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP, Drug Design, Development and Therapy, Oral Formulation The only available oral GLP-1RA is semaglutide (Rybelsus, Novo Nordisk)
has received consulting fees from Amgen, AstraZeneca Inc., Insulet, Kallyope and Pfizer Inc
Decision Support Tool: Features to Consider in Determining if a Clinical Trial is Phase II or Phase III
Use of DPP4 inhibitors and GLP-1 receptor agonists and risk of intestinal obstruction: Scandinavian cohort study
No single or dual-agonist compound can replicate the combined effects on appetite regulation, insulin secretion, lipolysis, and thermogenesis that retatrutide produces in research settings